4
Changes in Ownership
ENDRA Life Sciences Inc. Filed Acc 0001209191-21-003597
Chief Commercial Officer sold 20,000 shares at an average $1.08 ($21,685)
From the SEC's structured data for this filing
Trades in this filing
Maloberti Renaud Bertrand · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-12 | Sale : show line 1 in the form | −6,304 | $1.05 | $6,619 | 15,276 | D |
| 2021-01-13 | Sale : show line 2 in the form | −13,696 | $1.10 | $15,066 | 1,580 | D |
| Open-market sales · 20,000 sh · avg $1.08 · $21,685 | ||||||
Loading xslF345X03/doc4.xml…